Honokiol: A naturally occurring lignan with pleiotropic bioactivities

被引:38
作者
Chen Cheng [1 ]
Zhang Qing-Wen [1 ]
Ye Yang [2 ]
Lin Li-Gen [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Honokiol; Natural sources; Ethnopharmacological uses; Physicochemical properties; Bioactivities; Clinical trials; ANTIDEPRESSANT-LIKE SYNERGISM; INDUCED CELLULAR-RESPONSES; ACTIVATED PROTEIN-KINASE; ALCOHOLIC FATTY LIVER; KAPPA-B ACTIVATION; MAGNOLIA-OFFICINALIS; IN-VITRO; INSULIN-RESISTANCE; SIGNALING PATHWAY; OXIDATIVE STRESS;
D O I
10.1016/S1875-5364(21)60047-X
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Honokiol is the dominant biphenolic compound isolated from the Magnolia tree, and has long been considered as the active constituent of the traditional Chinese herb, 'Houpo', which is widely used to treat symptoms due to 'stagnation of qi'. Pharma-cological studies have shown that honokiol possesses a wide range of bioactivities without obvious toxicity. Honokiol protects the liver, kidneys, nervous system, and cardiovascular system through reducing oxidative stress and relieving inflammation. Moreover, honokiol shows anti-diabetic property through enhancing insulin sensitivity, and anti-obese property through promoting browning of adipocytes. In vivo and in vitro studies indicated that honokiol functions as an anti-cancer agent through multiple mechanisms: inhibiting angiogenesis, promoting cell apoptosis, and regulating cell cycle. A variety of therapeutic effects of honokiol may be associated with its physiochemical properties, which make honokiol readily cross the blood brain barrier and the blood-cerebrospinal fluid barrier, with high bioavailability. In the future, more clinical researches on honokiol are needed to fully authenticate its therapeutic values.
引用
收藏
页码:481 / 490
页数:10
相关论文
共 89 条
[71]   The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats [J].
Wang Jun-jun ;
Miao Xiao-lei ;
Chen Jing-ya ;
Chen Yong .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) :587-594
[72]   Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review [J].
Wang, Limei ;
Waltenberger, Birgit ;
Pferschy-Wenzig, Eva-Maria ;
Blunder, Martina ;
Liu, Xin ;
Malainer, Clemens ;
Blazevic, Tina ;
Schwaiger, Stefan ;
Rollinger, Judith M. ;
Heiss, Elke H. ;
Schuster, Daniela ;
Kopp, Brigitte ;
Bauer, Rudolf ;
Stuppner, Hermann ;
Dirsch, Verena M. ;
Atanasov, Atanas G. .
BIOCHEMICAL PHARMACOLOGY, 2014, 92 (01) :73-89
[73]   Honokiol, a Polyphenol Natural Compound, Attenuates Cisplatin-Induced Acute Cytotoxicity in Renal Epithelial Cells Through Cellular Oxidative Stress and Cytoskeleton Modulations [J].
Wang, Tse-En J. ;
Liu, Hung-Ting ;
Lai, Yu-Hua ;
Jan, Tong-Rong ;
Nomura, Naohiro ;
Chang, Hui-Wen ;
Chou, Chi-Chung ;
Lee, Ya-Jane ;
Tsai, Pei-Shiue J. .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[74]   Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model [J].
Wang, Xianhuo ;
Duan, Xingmei ;
Yang, Guangli ;
Zhang, Xiaoyan ;
Deng, Linyu ;
Zheng, Hao ;
Deng, Chongyang ;
Wen, Jiaolin ;
Wang, Ning ;
Peng, Cheng ;
Zhao, Xia ;
Wei, Yuquan ;
Chen, Lijuan .
PLOS ONE, 2011, 6 (04)
[75]   Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model [J].
Wen, Jing ;
Fu, A-fu ;
Chen, Li-Juan ;
Xie, Xing-Jiang ;
Yang, Guang-Li ;
Chen, Xian-Cheng ;
Wang, Yong-Sheng ;
Li, Jiong ;
Chen, Ping ;
Tang, Ming-Hai ;
Shao, Xi Ming ;
Lu, You ;
Zhao, Xia ;
Wei, Yu-Quan .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (11) :2709-2718
[76]   Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells [J].
Wu, Fang ;
Zhang, Wei ;
Li, Lin ;
Zheng, Fenping ;
Shao, Xueting ;
Zhou, Jiagiang ;
Li, Hong .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 654 (01) :117-121
[77]   Honokiol: an effective inhibitor of high-glucose-induced upregulation of inflammatory cytokine production in human renal mesangial cells [J].
Wu, Jian-Ping ;
Zhang, Wei ;
Wu, Fang ;
Zhao, Ying ;
Cheng, Lin-Fang ;
Xie, Jun-Jun ;
Yao, Hang-Ping .
INFLAMMATION RESEARCH, 2010, 59 (12) :1073-1079
[78]   Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents [J].
Xu, Qun ;
Yi, Li-Tao ;
Pan, Ying ;
Wang, Xing ;
Li, Yu-Cheng ;
Li, Jian-Mei ;
Wang, Cai-Ping ;
Kong, Ling-Dong .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (03) :715-725
[79]   Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice [J].
Yi, Li-Tao ;
Xu, Qun ;
Li, Yu-Cheng ;
Yang, Lei ;
Kong, Ling-Dong .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (04) :616-624
[80]   Magnolia officinalis Reverses Alcoholic Fatty Liver by Inhibiting the Maturation of Sterol Regulatory Element-Binding Protein-1c [J].
Yin, Hu-Quan ;
Je, Young-Tae ;
Kim, Young-Chul ;
Shin, Young-Kee ;
Sung, SangHyun ;
Lee, KiYong ;
Jeong, Gil-Saeng ;
Kim, Youn-Chul ;
Lee, Byung-Hoon .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 (04) :486-495